CompanyGraph
BioGaia AB
BIOG.B · Nasdaq Stockholm · Sweden
Price data from its BIOGBs listing on CBOE
biogaiagroup.comFinancials as of FY2025
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.16B, above the global median of $1.15B
- FinancialsHigh earnings quality
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.45%Above 5Y avg (1.29%)
Annual Rate
SEK 4.00Paid annual
Payout Ratio
47.8%Sustainable
Last Ex-Dividend
May 8, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
11.04BSEK1.16B · vs all stocks (USD)
Trailing P/E
33.44xRevenue (TTM)
1.58BSEK166.53M · vs all stocks (USD)
Profit Margin
21.97%Beta
0.3190xvs all stocks
52-Week Change
18.08%vs all stocks
Market Capitalization
11.04BSEK1.16B · vs all stocks (USD)
Enterprise Value
11.16BSEK1.18B · vs all stocks (USD)
Trailing P/E
33.44xForward P/E
26.49xPEG Ratio
1.15xPrice to Sales (TTM)
7.34xPrice to Book (MRQ)
10.54xEnterprise to Revenue
7.06xEnterprise to EBITDA
24.54xGross Margin
72.79%Profit Margin
21.97%Operating Margin
28.39%Return on Assets (TTM)
19.77%Return on Equity (TTM)
30.79%Revenue (TTM)
1.58BSEK166.53M · vs all stocks (USD)
Revenue per Share (TTM)
15.63SEKUpdated Aug 21, 2026Quarterly Revenue Growth
8.90%Gross Profit (TTM)
1.15BSEK121.59M · vs all stocks (USD)
EBITDA (TTM)
498.83MSEK52.56M · vs all stocks (USD)
Net Income (TTM)
347.23MSEK36.58M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
17.40%Operating Cash Flow (TTM)
314.80MSEK33.17M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
228.55MSEK24.08M · vs all stocks (USD)
Trailing Annual Dividend Rate
4.00SEKUpdated Aug 21, 2026Trailing Annual Dividend Yield
3.45%vs all stocks
5-Year Average Dividend Yield
1.29%vs all stocks
Payout Ratio
47.81%Minority Interest (Equity)
2.00KSEKFY2025 · Dec 31, 2025Revenue
1.54BSEKFY2025 · Dec 31, 2025Cost of Goods Sold
409.59MSEKFY2025 · Dec 31, 2025Gross Profit
1.13BSEKFY2025 · Dec 31, 2025Operating Income
451.97MSEK47.62M · vs all stocks (USD)
Pre-tax Income
421.22MSEKFY2025 · Dec 31, 2025Income Tax Expense
88.45MSEKFY2025 · Dec 31, 2025Net Income
332.76MSEKFY2025 · Dec 31, 2025EBIT
427.28MSEKFY2025 · Dec 31, 2025EBITDA (Income Statement)
454.27MSEKFY2025 · Dec 31, 2025Research & Development
115.72MSEKFY2025 · Dec 31, 2025Selling, General & Administrative
560.89MSEKFY2025 · Dec 31, 2025Other Operating Expenses
39.51MSEKFY2025 · Dec 31, 2025Non-operating Interest Income
17.20MSEKFY2025 · Dec 31, 2025Non-operating Interest Expense
6.06MSEKFY2025 · Dec 31, 2025EPS (Basic)
3.29SEKFY2025 · Dec 31, 2025EPS (Diluted)
3.29SEKFY2025 · Dec 31, 2025Basic Shares Outstanding
101.16MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
101.16MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
412.47MSEKFY2025 · Dec 31, 2025Minority Interests (P&L)
0.00SEKFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00SEKFY2025 · Dec 31, 2025Operating Cash Flow
368.60MSEKFY2025 · Dec 31, 2025Free Cash Flow
365.33MSEKFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
801.31MSEKFY2025 · Dec 31, 2025Starting Profit (CF Statement)
412.47MSEKFY2025 · Dec 31, 2025Other Non-cash Items
8.83MSEKFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-40.09MSEKFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-12.60MSEKFY2025 · Dec 31, 2025Capital Expenditures
-3.27MSEKFY2025 · Dec 31, 2025Net Intangibles (CF)
-75.00KSEKFY2025 · Dec 31, 2025Net Investing Cash Flow
-3.27MSEKFY2025 · Dec 31, 2025Common Dividends Paid
-698.02MSEKFY2025 · Dec 31, 2025Other Financing Charges
-5.00MSEKFY2025 · Dec 31, 2025Net Financing Cash Flow
-703.02MSEKFY2025 · Dec 31, 2025Shares Outstanding
101.16MSharesUpdated Aug 21, 2026Float Shares
83.94MSharesUpdated Aug 21, 2026% Held by Insiders
17.00%vs all stocks
% Held by Institutions
53.51%vs all stocks
Total Cash (MRQ)
446.27MSEK47.02M · vs all stocks (USD)
Total Cash per Share (MRQ)
4.41SEKUpdated Aug 21, 2026Total Debt (MRQ)
0.00SEKvs all stocks (USD)
Total Debt to Equity (MRQ)
0.00xCurrent Ratio (MRQ)
4.44xBook Value per Share (MRQ)
10.88SEKUpdated Aug 21, 2026Total Assets
1.60BSEK168.34M · vs all stocks (USD)
Total Current Assets
1.22BSEKFY2025 · Dec 31, 2025Total Liabilities
283.59MSEKFY2025 · Dec 31, 2025Total Non-current Assets
378.73MSEKFY2025 · Dec 31, 2025Total Non-current Liabilities
84.44MSEKFY2025 · Dec 31, 2025Total Current Liabilities
199.14MSEKFY2025 · Dec 31, 2025Cash & Cash Equivalents
801.31MSEKFY2025 · Dec 31, 2025Accounts Receivable
216.17MSEKFY2025 · Dec 31, 2025Inventory
166.70MSEKFY2025 · Dec 31, 2025Accounts Payable
56.66MSEKFY2025 · Dec 31, 2025Other Current Liabilities
17.79MSEKFY2025 · Dec 31, 2025Other Non-current Liabilities
79.49MSEKFY2025 · Dec 31, 2025Common Stock (Book)
20.23MSEKFY2025 · Dec 31, 2025Retained Earnings
123.16MSEKFY2025 · Dec 31, 2025Total Shareholders' Equity
1.31BSEK138.47M · vs all stocks (USD)
52-Week Low
96.20SEKUpdated Aug 21, 202652-Week High
136.30SEKUpdated Aug 21, 202652-Week Change
18.08%vs all stocks
Beta
0.3190xvs all stocks
50-Day MA
117.08SEKUpdated Aug 21, 2026200-Day MA
113.53SEKUpdated Aug 21, 2026Avg 10-Day Volume
150.65KSharesUpdated Aug 21, 2026Avg 30-Day Volume
154.02KSharesUpdated Aug 21, 2026Diluted EPS (TTM)
3.43SEKUpdated Aug 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
High earnings qualityNotable
Earnings Quality Score: 0.63
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.16B, above the global median of $1.15BNotable
Market cap (USD): 1,162,838,071.704Global Median: 1,146,734,693.424
Levered free cash flow is $24.08M, above the global median of $16.24MNotable
Levered free cash flow (USD): 24,080,080.259Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Sanofi Consumer Healthcare Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Northeast Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Eton Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Guilin Sanjin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Glass House Brands Inc.
Tier 1ProductionApproval-Gated PipelineFlowRule
Zhejiang Tianyu Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Avanos Medical Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Collegium Pharmaceutical Inc.
Tier 1ProductionApproval-Gated PipelineRule
Tandem Diabetes Care Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Zhejiang Garden Bio-chemical High-tech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Jiangsu Hengli Hydraulic Co., Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
H. Lundbeck A/S
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Mastercard Incorporated
1 interpretationMulti-Year Revenue, Profit, And Income Growth